Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products
Health and Human Services Department; Food and Drug Administration · 2011
Read Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products by Health and Human Services Department; Food and Drug Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-10618.txt.
Description
Notice published in the Federal Register on 2011-05-03 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [Pages 24888-24889] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-10618] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0044] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry.
Catalog record
| CREATOR | Health and Human Services Department; Food and Drug Administration |
|---|---|
| YEAR | 2011 |
| COLLECTION | LAW |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Federal Register |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products
Citation: us:fr:2011-10618
Creator: Health and Human Services Department; Food and Drug Administration
Year: 2011
Source-URL: https://www.federalregister.gov/documents/2011/05/03/2011-10618/agency-information-collection-activities-submission-for-office-of-management-and-budget-review
Context: Notice published in the Federal Register on 2011-05-03 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo).
[Pages 24888-24889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-10618]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0044]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Guidance for Industry
and Food and Drug Administration Staff; Section 905(j) Reports:
Demonstrating Substantial Equivalence for Tobacco Products
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review under the Paperwork Reduction
Act of 1995.
DATES: Fax written comments on the collection of information by June 2,
2011.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that the written comments be faxed to the
Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk
Officer. Fax: 202-395-7285, or e-mailed to [email protected]. All comments should be identified with the OMB
control number 0910-0673. Also include the FDA docket number found in
brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-3792,
[email protected].
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance: Information Request Regarding Guidance for
Industry and FDA Staff; Section 905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco Products--(OMB Control Number 0910-
0673)--Extension.
On June 22, 2009, the President signed the Family Smoking
Prevention and Tobacco Control Act (the Tobacco Control Act) (Pub. L.
111-31) into law. The Tobacco Control Act amended the Federal Food,
Drug, and Cosmetic Act (the FD&C Act) by adding a new chapter granting
FDA important new authority to regulate the manufacture, marketing, and
distribution of tobacco products to protect the public health generally
and to reduce tobacco use by minors.
Section 905(j)(1) of the FD&C Act authorizes FDA to establish the
form and manner for the submission of information related to
substantial equivalence (21 U.S.C. 387e(j)(1)). In a level 1 guidance
document issued under the Good Guidances Practices regulation (21 CFR
10.115), FDA provides recommendations intended to assist persons
submitting reports under section 905(j) of the FD&C Act, and explains,
among other things, FDA's interpretation of the statutory sections
related to substantial equivalence (see ``Guidance for Industry and FDA
Staff--Section 905(j) Reports: Demonstrating Substantial Equivalence
for Tobacco Products'' (January 6, 2011, 76 FR 789).)
In the Federal Register of January 24, 2011 (76 FR 4116), FDA
published a 60-day notice requesting public comment on the proposed
information collection.
FDA received one comment in response to the 60-day notice. The
commenter indicated that the substantial equivalence requirements were
``burdensome to industry in the extreme,'' that FDA's estimation of the
number of reports to be received was too low, and that the current
burden hours to complete each report was unrealistic. Although the
commenter asserted that the burden hours were too low and unrealistic,
no alternative estimates were provided.
The recommendations in the ``Guidance for Industry and FDA Staff--
Section 905(j) Reports: Demonstrating Substantial Equivalence for
Tobacco Products'' are the information that FDA suggests a manufacturer
include in a report submitted under section 905(j)(1)(A)(i) of the FD&C
Act. The recommendations reflect the information FDA believes is
necessary for it to make the required findings under section 910(a) of
the FD&C Act (21 U.S.C. 387j(a)). FDA has also articulated current
enforcement policies in its guidances that are intended to address some
of the burden associated with premarket requirements for new tobacco
products (manufacturers and interested parties may refer to FDA's
[[Page 24889]]
Web site for guidance documents with current enforcement policies
related to premarket requirements for tobacco products (http://www.fda.gov/TobaccoProducts/default.htm)).
With regard to the comment that the number of section
905(j)(1)(A)(i) substantial equivalence reports which FDA estimated to
be submitted (150 per year) was too low, FDA has revised its estimate
based on information it now has from initial submissions, interactions
with industry, and other information, such as the comment received on
the 60-day notice on the information collection. As shown below, FDA is
increasing the annual estimate of the number of reports received from
150 to 1,000.
With regard to the comment that the number of hours to prepare and
submit each report is unrealistic, FDA continues to believe that the
currently estimated hours (360 hours annually) is appropriate,
particularly given that the premarket requirements for new tobacco
products (Section 910 of the FD&C Act) are new and manufacturers'
experience with preparing a submission is just beginning to develop. As
the requirements and program become more familiar to respondents, FDA
may be able to refine these estimates. In addition, as discussed
previously, the commenter did not suggest an alternative number of
hours. FDA's estimate of 360 hours reflects an amount of time that
should provide each submitter enough time to prepare and submit a
section 905(j)(1)(A)(i) substantial equivalence report to the Agency.
Estimation of Burden
FDA estimates the burden for this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total annual burden per
FD&C Act sections respondents responses per responses response (in Total hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
905(j)(a)(A)(i) and 910(a)...... 1,000 1 1,000 360 360,000
Total....................... .............. .............. .............. .............. 360,000
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
FDA has based these estimates on information it now has available
from interactions with the industry, comments regarding the submission
of 905(j)(1)(A)(i) substantial equivalence reports, and comments on the
60-day information collection notice request for comments published in
the Federal Register on January 24, 2011 (76 FR 4116). Table 1 of this
document describes the annual reporting burden as a result of the
implementation of the substantial equivalence requirements of sections
905(j)(1)(A)(i) and 910(a) of the FD&C Act. FDA estimates that it will
receive 1,000 section 905(j) substantial equivalence reports each year
and that it will take a manufacturer approximately 360 hours to prepare
a report of substantial equivalence for a new tobacco product.
Therefore, FDA estimates the burden for submission of substantial
equivalence information will be 360,000 hours.
Dated: April 27, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-10618 Filed 5-2-11; 8:45 am]